Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis

Free Subscription Articles published in Transplantation Retrieve available abstracts of 18 articles: HTML format

Single Articles

January 2023
1. HUME SJ, Thompson AJ, Holmes JA
   Editorial on "Maximize Donor Cornea Use in a Hepatitis B Endemic Area via Serology Matching".
   Transplantation. 2023 Jan 25. doi: 10.1097/TP.0000000000004461.
   PubMed    
   
   
   
2. CHU HS, Killeen OJ, Hsieh YT, Su TH, et al
   Maximize Donor Cornea Use in a Hepatitis B Endemic Area via Serology Matching.
   Transplantation. 2023 Jan 25. doi: 10.1097/TP.0000000000004460.
   PubMed     Abstract available
   
   
   November 2022
3. MYERS B, Bekki Y, Kozato A, Crismale JF, et al
   DCD Hepatitis C Virus-positive Donor Livers Can Achieve Favorable Outcomes With Liver Transplantation and Are Underutilized.
   Transplantation. 2022 Nov 7. pii: 00007890-990000000-00240.
   PubMed     Abstract available
   
   
   October 2022
4. WOOLLEY AE, Gandhi AR, Jones ML, Kim JJ, et al
   The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients.
   Transplantation. 2022 Oct 27. doi: 10.1097/TP.0000000000004378.
   PubMed     Abstract available
   
   
   May 2022
5. SIBULESKY L, Leca N, Limaye AP, Ramasamy B, et al
   Survival Benefit in Older Patients Transplanted With Viremic Hepatitis C Positive Kidneys When Compared With High KDPI Kidneys.
   Transplantation. 2022 May 27. pii: 00007890-990000000-00059.
   PubMed     Abstract available
   
   
   April 2022
6. MARTINI S, Tandoi F, Romagnoli R, Rizzetto M, et al
   Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients.
   Transplantation. 2022 Apr 11. pii: 00007890-990000000-00024.
   PubMed     Abstract available
   
   
   
7. BEKKI Y, Crismale JF, Myers B, Schiano TD, et al
   Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the US: An Analysis of the OPTN/UNOS Database.
   Transplantation. 2022 Apr 6. pii: 00007890-990000000-00025.
   PubMed     Abstract available
   
   
   
8. GUPTA G, Devarakonda T, Sharma A, Miles M, et al
   Ultrashort Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants.
   Transplantation. 2022;106:e234-e235.
   PubMed    
   
   
   March 2022
9. BITTERMANN T, Mahmud N, Weinberg EM, Reddy KR, et al
   Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
   Transplantation. 2022 Mar 24. pii: 00007890-900000000-95041.
   PubMed     Abstract available
   
   
   
10. TROTTER J
    Commentary on Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Transplantation. 2022 Mar 24. pii: 00007890-900000000-95040.
    PubMed    
    
    
    February 2022
11. COTTER TG, Charlton M
    The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients.
    Transplantation. 2022;106:e166.
    PubMed    
    
    
    
12. BEKKI Y, Myers B
    Geographic Variation in the Utilization of HCV-viremic Donors into HCV-negative Recipients.
    Transplantation. 2022;106:e165.
    PubMed    
    
    
    
13. LIN SH, Lin MT, Wang CC, Chen CL, et al
    Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure.
    Transplantation. 2022;106:e163-e164.
    PubMed    
    
    
    
14. WALLER KMJ, De La Mata NL, Rosales BM, Hedley JA, et al
    Characteristics and Donation Outcomes of Potential Organ Donors Perceived to Be at Increased Risk for Blood-borne Virus Transmission: An Australian Cohort Study 2010-2018.
    Transplantation. 2022;106:348-357.
    PubMed     Abstract available
    
    
    July 2021
15. RICHTER BI, Parent B, Lonze BE
    The Moral Necessity to Increase Access to HCV+ Transplants With Early Treatment for HCV Naive Patients.
    Transplantation. 2021 Jul 22. pii: 00007890-900000000-95189.
    PubMed    
    
    
    May 2021
16. MUTHUKUMAR T, Akat KM, Yang H, Schwartz JE, et al
    Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study.
    Transplantation. 2021 May 11. pii: 00007890-900000000-95253.
    PubMed     Abstract available
    
    
    February 2021
17. HUCKABY LV, Seese LM, Handzel R, Wang Y, et al
    Center-level Utilization of Hepatitis C Virus Positive Donors for Orthotopic Heart Transplantation.
    Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003674.
    PubMed     Abstract available
    
    
    December 2020
18. ADENUGBA A, Hornung M, Weigand K, Peschel G, et al
    Ribavirin Improves NK Cell IFNgamma Response During Sofosbuvir-based DAA Therapy in CV-infected Liver Transplant Recipients.
    Transplantation. 2020 Dec 29. pii: 00007890-900000000-95432.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: